McLaren Health Care Joins SharedClarity in Effort to Control Cost, Improve Patient Health
PHOENIX, Ariz. & FLINT, Mich.--(BUSINESS WIRE)--McLaren Health Care, a leading fully integrated health care network in Michigan, has become the fourth health care system member of SharedClarity, a startup conducting independent studies to determine the most effective medical devices in order to improve patient outcomes and reduce costs.
“We’re looking for health care systems that are a good strategic fit for with our existing members”
McLaren Health Care announced its membership today in SharedClarity, joining San Francisco-based Dignity Health, Dallas-based Baylor Scott & White Health, Illinois-based Advocate Health Care and health benefits provider UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company. SharedClarity, based in Phoenix, launched in April 2013.
“We’re extremely excited about becoming a member of SharedClarity,” said McLaren President and CEO Philip A. Incarnati. “SharedClarity will help to improve supply chain efficiency and patient outcomes.”
McLaren has 11 acute-care hospitals, 20,000 network physicians and 19,500 employees. The health care system, which has $3 billion in annual revenue, serves a market of about 6.5 million people in Michigan.
In 2013, McLaren embraced an aggressive effort to better manage costs in order to save $100 million of redundant and unnecessary spending from its structures and processes.
“We’re very proud to have McLaren join SharedClarity,” said SharedClarity President Mark West. “We are building a company that will change how health care systems select and purchase high-quality medical devices – and improve patient outcomes and affordability across the system.”
SharedClarity improves patient outcomes by identifying the most effective medical devices in a number of categories, including stents, defibrillators, pacemakers, knee and hip implants, and heart valves.
“From a population health perspective, we’re responsible for giving patients better service and delivering value,” said Dr. Mike McKenna, chief medical officer of McLaren Health Care. “Health care organizations that can do this going forward, by improving outcomes and efficiency, will be the winners.”
SharedClarity conducts independent studies to determine the most effective implants for patients and negotiates market-leading purchasing agreements with device manufacturers. U.S. hospitals spend more than $30 billion annually on the 30 most frequently used categories of devices, according to industry reports.
The SharedClarity medical device studies are overseen by physicians from each of the member health systems – including McLaren – using data from member hospitals and claims information from UnitedHealthcare, which provides benefits to more than 40 million Americans.
Optum Labs is the data and research partner for SharedClarity with consultants from The Lewin Group, long known for its independent research in the health care industry, overseeing the research. Optum Labs and Lewin Group are UnitedHealth Group affiliates that provide information and technology-enabled health services.
In addition to market-leading pricing for implants, SharedClarity helps health care systems lower costs by reducing readmissions, an increased concern for health care officials under the Affordable Care Act.
SharedClarity is currently meeting with other health care systems that could become member-owners.
“We’re looking for health care systems that are a good strategic fit for with our existing members,” Mr. West said. “Our goal is to change how health care systems evaluate and source medical devices, and that requires members who are ready and willing to challenge the status quo while saving money and improving patient outcomes.”
About McLaren Health Care
McLaren Health Care Corporation, headquartered in Flint, MI, is a fully integrated health network committed to quality, evidence-based patient care and cost efficiency. The McLaren system includes 11 hospitals, ambulatory surgery centers, imaging centers, the state’s only proton therapy center, an employed primary care physician network, commercial and Medicaid HMOs covering over 250,000 lives, home health care and hospice, durable medical equipment, retail pharmacy services and a wholly owned medical malpractice insurance company. McLaren operates the state’s largest network of cancer centers and providers anchored by Karmanos Cancer Institute – one of only two NCI-designated cancer centers in the state. McLaren has 19,500 employees and more than 20,000 network physicians. The operations and services of MHC are housed in over 300 facilities serving a 53-county market with a population in excess of 6.5 million lives. Learn more at www.mclaren.org.
SharedClarity is a unique joint effort between health care systems and UnitedHealthcare to use data from tens of millions of patients to study the long-term effectiveness of high-technology medical devices that have a high impact on patients. SharedClarity will use the results of the studies to select the most effective medical devices for patients and negotiate affordable purchasing agreements with manufacturers. For more information, please visit www.SharedClarity.net.